Certainly a lot going on in the diabetic wound healing arena, which also means more competition for CYP as it tackles DFU's .... interesting read for those interested
In vivo, dual-crosslinked hydrogels contributed to faster diabetic #WoundHealing than PRP and SP by upregulating growth factor expression, down-regulating matrix metalloproteinase-9 expression, and by promoting an anti-NETotic effect.
https://www.sciencedirect.com/science/article/pii/S2452199X23001469?via=ihub
Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressings
- Forums
- ASX - By Stock
- CYP
- Ann: Cynata Adds New Sites for DFU Clinical Trial
CYP
cynata therapeutics limited
Add to My Watchlist
9.09%
!
18.0¢

Ann: Cynata Adds New Sites for DFU Clinical Trial, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $40.67M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $29.91K | 170.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 27622 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 0.175 |
1 | 62866 | 0.170 |
2 | 60542 | 0.165 |
2 | 27975 | 0.160 |
3 | 181290 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 27622 | 2 |
0.185 | 135916 | 3 |
0.190 | 66916 | 2 |
0.195 | 9659 | 3 |
0.200 | 55400 | 2 |
Last trade - 15.57pm 28/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online